Orthopedic Soft Tissue Repair Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Orthopedic Soft Tissue Repair Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The global orthopedic soft tissue repair market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028.

Orthopedic soft tissue repair refers to the process of replacing the injured or damaged tissues with healthy tissues. It comprises nerves, ligaments, blood vessels, muscles, tendons and synovial membranes. Orthopedic soft tissue injuries often occur during sports and physical activities but can also be caused by simple everyday tasks and continuous use of a particular body part. Sprains, strains, bursitis, contusions, and tendinitis are some of the common soft tissue injuries that can result in swelling, pain, bruising and loss of function. The repair of orthopedic soft tissues can be performed through open surgical processes or by complete minimally invasive procedures such as arthroscopy. These procedures increase mobility, muscle strength, tissue length, and range of movement with reduced pain and swelling, thereby enhancing the healing process.

Orthopedic Soft Tissue Repair Market Trends:
The rising geriatric population across the globe, which is more susceptible to injuries as a result of weakened ligaments and changes in skeletal and neuromuscular systems, is primarily driving the market growth. Additionally, the growing participation of individuals in professional sports has significantly increased the risks of sports-related injuries, which, in turn, is facilitating the demand for orthopedic soft tissue repair procedures. Apart from this, the introduction of new therapies, such as platelet-rich plasma, that are effective in managing complex neuromuscular pain caused due to orthopedic ligament tears are providing an impetus to the market growth. In line with this, the introduction of new technologies, including bioprinting, biological meshes, and biofabrication, is further creating a positive outlook for the market. Other factors, including extensive research and development (R&D) activities, innovations in new devices and therapies, and increasing healthcare per capita expenditure, are anticipated to drive the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global orthopedic soft tissue repair market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on procedure, injury location and end user.

Breakup by Procedure:

Cruciate Ligaments Repair
Rotator Cuff Repair
Lateral Epicondylitis
Achilles Tendinosis Repair
Pelvic Organ Prolapse
Gluteal Tendon Repair
Hip Arthroscopy
Biceps Tenodesis
Others

Breakup by Injury Location:

Knee
Shoulder
Hip
Small Joints

Breakup by End User:

Hospitals
Ambulatory Centers
Orthopedic Clinics

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., Becton Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Integra LifeSciences, Johnson & Johnson, LifeNet Health, MTF Biologics, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Group plc and Zimmer Biomet.

Key Questions Answered in This Report:
How has the global orthopedic soft tissue repair market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global orthopedic soft tissue repair market?
What are the key regional markets?
What is the breakup of the market based on the procedure?
What is the breakup of the market based on the injury location?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global orthopedic soft tissue repair market and who are the key players?
What is the degree of competition in the industry?